Krystal Biotech (KRYS) Interest & Investment Income (2017 - 2026)
Krystal Biotech recorded quarterly Interest & Investment Income of $7.8 million in Q1 2026, up 13.0% quarter-over-quarter from $6.9 million in Q4 2025, and up 5.55% year-over-year from $7.3 million in Q1 2025.
Krystal Biotech's Interest & Investment Income history runs 10 years deep, the most recent figure standing at $7.8 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 5.55% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $28.7 million (down 2.32% YoY), while the FY2025 annual figure was $28.2 million, down 4.84% from the prior year.
- Interest & Investment Income came in at $7.8 million for Q1 2026 at Krystal Biotech, up from $6.9 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $7.8 million in Q1 2026 to a low of $257000.0 in Q1 2022.
- A 5-year average of $5.5 million and a median of $6.9 million in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 3784.29% in 2022 and fell 9.65% in 2025, its largest moves.
- Krystal Biotech's Interest & Investment Income stood at $2.7 million in 2022, then jumped by 172.49% to $7.4 million in 2023, then decreased by 2.35% to $7.2 million in 2024, then slipped by 5.17% to $6.9 million in 2025, then grew by 13.0% to $7.8 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $7.8 million, $6.9 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | 7.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.75 Mn |
| Dec 31, 2025 | 6.86 Mn |
| Sep 30, 2025 | 6.59 Mn |
| Jun 30, 2025 | 7.47 Mn |
| Mar 31, 2025 | 7.35 Mn |
| Dec 31, 2024 | 7.24 Mn |
| Sep 30, 2024 | 7.30 Mn |
| Jun 30, 2024 | 7.48 Mn |
| Mar 31, 2024 | 7.62 Mn |
| Dec 31, 2023 | 7.41 Mn |
| Sep 30, 2023 | 6.74 Mn |
| Jun 30, 2023 | 4.84 Mn |
| Mar 31, 2023 | 3.53 Mn |
| Dec 31, 2022 | 2.72 Mn |
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 645,000.00 |
| Mar 31, 2022 | 257,000.00 |
| Dec 31, 2021 | 70,000.00 |
| Sep 30, 2021 | 63,000.00 |
| Jun 30, 2021 | 30,000.00 |
| Mar 31, 2021 | 33,000.00 |
| Dec 31, 2020 | 37,000.00 |
| Sep 30, 2020 | 70,000.00 |
| Jun 30, 2020 | 121,000.00 |
| Mar 31, 2020 | 605,000.00 |
| Dec 31, 2019 | 797,000.00 |
| Sep 30, 2019 | 1.07 Mn |
| Jun 30, 2019 | 542,000.00 |
| Mar 31, 2019 | 583,000.00 |
| Dec 31, 2018 | 511,000.00 |
| Sep 30, 2018 | 217,000.00 |
| Jun 30, 2018 | 173,000.00 |
| Mar 31, 2018 | 127,000.00 |
| Dec 31, 2017 | 105,000.00 |
| Sep 30, 2017 | -3.18 Mn |
| Jun 30, 2017 | -44,000.00 |
| Mar 31, 2017 | -29,000.00 |